Tatsuo Aoki
About
Tatsuo Aoki is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Surgery.
According to data from OpenAlex, Tatsuo Aoki has authored 79 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Cardiology and Cardiovascular Medicine, 47 papers in Pulmonary and Respiratory Medicine and 17 papers in Surgery. Recurrent topics in Tatsuo Aoki's work include Pulmonary Hypertension Research and Treatments (42 papers), Cardiovascular Function and Risk Factors (15 papers) and Cardiovascular Issues in Pregnancy (12 papers). Tatsuo Aoki is often cited by papers focused on Pulmonary Hypertension Research and Treatments (42 papers), Cardiovascular Function and Risk Factors (15 papers) and Cardiovascular Issues in Pregnancy (12 papers). Tatsuo Aoki collaborates with scholars based in Japan, United States and Canada. Tatsuo Aoki's co-authors include Hiroaki Shimokawa, Yoshihiro Fukumoto, Koichiro Sugimura, Shunsuke Tatebe, Kimio Satoh, Kotaro Nochioka, Satoshi Miyata, Yutaka Miura, Nobuhiro Yaoita and Saori Yamamoto and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and PLoS ONE.
In The Last Decade
Tatsuo Aoki
72 papers receiving 2.0k citations
Peers
Tatsuo Aoki
William B. Hillegass United States
Zhenguo Zhai China
Yuanhua Yang China
L. Sunder-Plassmann Germany
Gilles Garcia France
Edmund Lau Australia
Hanno Leuchte Germany
Martin Ellis Israel
Carlo V. Feo Italy
Eduardo de Marchena United States
Citations per year, relative to Tatsuo Aoki Tatsuo Aoki (= 1×)
peers
William B. Hillegass
Countries citing papers authored by Tatsuo Aoki
Since
Specialization
Citations
This map shows the geographic impact of Tatsuo Aoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tatsuo Aoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tatsuo Aoki more than expected).
Fields of papers citing papers by Tatsuo Aoki
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Tatsuo Aoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tatsuo Aoki. The network helps show where Tatsuo Aoki may publish in the future.
Co-authorship network of co-authors of Tatsuo Aoki
This figure shows the co-authorship network connecting the top 25 collaborators of Tatsuo Aoki. A scholar is included among the top collaborators of Tatsuo Aoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tatsuo Aoki. Tatsuo Aoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Aoki, Tatsuo, Hiroyuki Endo, Takatoyo Kiko, et al.. (2025). Clinical impact of mean pulmonary arterial pressure after balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension. Open Heart. 12(2). e003532–e003532.
2.
Tsuji, Akihiro, Hiroyuki Endo, Takatoyo Kiko, et al.. (2024). Effect of direct oral anticoagulant therapy on pulmonary artery clot dissolution in intermediate high-risk pulmonary thromboembolism. Thrombosis Journal. 22(1). 60–60.
3.
Hirakawa, Kyoko, Ryotaro Asano, Jin Ueda, et al.. (2024). Calcium channel blockers in patients with pulmonary arterial hypertension receiving PAH-specific treatment. International Journal of Cardiology. 406. 132043–132043.
4.
Kiko, Takatoyo, Ryotaro Asano, Hiroyuki Endo, et al.. (2024). Balloon pulmonary angioplasty for chronic thromboembolic pulmonary disease without pulmonary hypertension. Pulmonary Circulation. 14(3). e12409–e12409.
5.
Kiko, Takatoyo, Ryotaro Asano, Tomohiko Ishibashi, et al.. (2024). Prevalence and Clinical Characteristics of Heterozygous RNF213 p.Arg4810Lys Variant Carriers Diagnosed With Chronic Thromboembolic Pulmonary Hypertension. Journal of the American Heart Association. 13(15). e035009–e035009.
6.
Satoh, Taijyu, Nobuhiro Yaoita, Kotaro Nochioka, et al.. (2023). Inhaled Nitric Oxide Testing in Predicting Prognosis in Pulmonary Hypertension Due to Left-Sided Heart Diseases. ESC Heart Failure. 10(6). 3592–3603.
7.
Sun, Wenyu, Hideki Ota, Haruka Sato, et al.. (2022). Systemic-pulmonary collateral supply associated with clinical severity of chronic thromboembolic pulmonary hypertension: a study using intra-aortic computed tomography angiography. European Radiology. 32(11). 7668–7679.
8.
Nakanishi, Michio, Hiroyuki Miura, Kazuhiro Nakao, et al.. (2022). Association of Adherence to a 3 Month Cardiac Rehabilitation with Long-Term Clinical Outcomes in Heart Failure Patients. ESC Heart Failure. 9(2). 1424–1435.
9.
Inoue, Yuko, Takashi Noda, Nobuhiko Ueda, et al.. (2021). Long term prognosis in patients with pulmonary hypertension undergoing catheter ablation for supraventricular tachycardia. Scientific Reports. 11(1). 16176–16176.
10.
Aoki, Tatsuo, Koichiro Sugimura, Shunsuke Tatebe, et al.. (2020). Beneficial effects of riociguat on hemodynamic responses to exercise in CTEPH patients after balloon pulmonary angioplasty – A randomized controlled study. IJC Heart & Vasculature. 29. 100579–100579.
11.
Kozu, Katsuya, Kimio Satoh, Tatsuo Aoki, et al.. (2019). Cyclophilin A as a biomarker for the therapeutic effect of balloon angioplasty in chronic thromboembolic pulmonary hypertension. Journal of Cardiology. 75(4). 415–423.
12.
Konno, Ryo, Shunsuke Tatebe, Koichiro Sugimura, et al.. (2019). Prognostic value of the model for end-stage liver disease excluding INR score (MELD-XI) in patients with adult congenital heart disease. PLoS ONE. 14(11). e0225403–e0225403.
13.
Sugimura, Koichiro, Tatsuo Aoki, Shunsuke Tatebe, et al.. (2019). Usefulness of ventilatory gas analysis for the non-invasive evaluation of the severity of chronic thromboembolic pulmonary hypertension. International Journal of Cardiology. 296. 149–154.
14.
Kamada, Hiroki, Hideki Ota, Tatsuo Aoki, et al.. (2019). 4D-flow MRI assessment of blood flow before and after endovascular intervention in a patient with pulmonary hypertension due to isolated pulmonary artery involvement in large vessel vasculitis. SHILAP Revista de lepidopterología. 15(3). 190–194.
15.
Aoki, Tatsuo, Koichiro Sugimura, Shunsuke Tatebe, et al.. (2017). Comprehensive evaluation of the effectiveness and safety of balloon pulmonary angioplasty for inoperable chronic thrombo-embolic pulmonary hypertension: long-term effects and procedure-related complications. European Heart Journal. 38(42). 3152–3159.
16.
Matsuzawa, Yasushi, Sara Svedlund, Tatsuo Aoki, et al.. (2015). Utility of both carotid intima–media thickness and endothelial function for cardiovascular risk stratification in patients with angina-like symptoms. International Journal of Cardiology. 190. 90–98.
17.
Matsuzawa, Yasushi, Tatsuo Aoki, Raviteja Guddeti, et al.. (2014). Predictive value of endothelial function by noninvasive peripheral arterial tonometry for coronary artery disease. Coronary Artery Disease. 26(3). 231–238.
18.
Matsuzawa, Yasushi, Tatsuo Aoki, Raviteja Guddeti, et al.. (2014). PREDICTIVE VALUE OF ENDOTHELIAL FUNCTION BY NON-INVASIVE PERIPHERAL ARTERIAL TONOMETRY FOR CORONARY ARTERY DISEASE. Journal of the American College of Cardiology. 63(12). A1578–A1578.
19.
Aoki, Tatsuo, Yoshihiro Fukumoto, Satoshi Yasuda, et al.. (2012). The Great East Japan Earthquake Disaster and cardiovascular diseases. European Heart Journal. 33(22). 2796–2803.
20.
Dai, Zhehao, Tatsuo Aoki, Yoshihiro Fukumoto, & Hiroaki Shimokawa. (2012). Coronary perivascular fibrosis is associated with impairment of coronary blood flow in patients with non-ischemic heart failure. Journal of Cardiology. 60(5). 416–421.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by William B. Hillegass Breakdown of academic impact, for papers by Zhenguo Zhai Breakdown of academic impact, for papers by Yuanhua Yang Breakdown of academic impact, for papers by L. Sunder-Plassmann Breakdown of academic impact, for papers by Gilles Garcia Breakdown of academic impact, for papers by Edmund Lau Breakdown of academic impact, for papers by Hanno Leuchte Breakdown of academic impact, for papers by Martin Ellis Breakdown of academic impact, for papers by Carlo V. Feo Breakdown of academic impact, for papers by Eduardo de Marchena